Literature DB >> 10362166

Dietary therapy for gestational diabetes: how long is long enough?

M B McFarland1, O Langer, D L Conway, M D Berkus.   

Abstract

OBJECTIVE: To determine the length of time required for dietary therapy alone to effect good glycemic control and whether the need for insulin treatment can be predicted at diagnosis of gestational diabetes mellitus (GDM).
METHODS: Women with GDM were treated with dietary therapy for 4 weeks. Each measured her blood glucose using a memory-based reflectance glucometer, and those in poor glycemic control (mean glucose exceeding 105 mg/dL) after 4 weeks of dietary therapy were prescribed insulin. Women were stratified by fasting plasma glucose value of 3-hour glucose tolerance tests (GTTs).
RESULTS: Women with fasting glucose at or below 95 mg/dL were significantly more likely to achieve good glycemic control after 2 weeks of dietary therapy than were those with values above 95 mg/dL whose control did not improve during the study. Receiver operating characteristic (ROC) analysis determined that fasting values of GTT between 91 and 95 mg/dL best predicted that insulin would be needed for good glycemic control.
CONCLUSION: Women with GDM should be prescribed dietary therapy alone for at least 2 weeks before they are prescribed insulin. In those with fasting glucose above 95 mg/dL, insulin may be prescribed after 1 week of dietary therapy, or at diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362166     DOI: 10.1016/s0029-7844(98)00547-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

Review 1.  Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions.

Authors:  Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus.

Authors:  Robyn A Barnes; Tang Wong; Glynis P Ross; Bin B Jalaludin; Vincent W Wong; Carmel E Smart; Clare E Collins; Lesley MacDonald-Wicks; Jeff R Flack
Journal:  Diabetologia       Date:  2016-07-08       Impact factor: 10.122

3.  Investigation of the correlation between 100 gram oral glucose tolerance test results and maternal leptin levels during pregnancy.

Authors:  Ozlem Baykara Sengül; Tamer Mungan; Evrim Erdemoğlu; Göksel Islamoğlu; Nuran Kıyak
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

4.  Characterization of women with gestational diabetes who failed to achieve glycemic control by lifestyle modifications.

Authors:  Eyal Krispin; Adi Ashkenazi Katz; Elyasaf Shmuel; Yoel Toledano; Eran Hadar
Journal:  Arch Gynecol Obstet       Date:  2020-09-03       Impact factor: 2.344

Review 5.  Controversies around gestational diabetes. Practical information for family doctors.

Authors:  Len Kelly; Laura Evans; David Messenger
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

6.  Gestational Diabetes Mellitus (GDM): Relationship Between Higher Cutoff Values for 100 g Oral Glucose Tolerance Test (OGTT) and Insulin Requirement During Pregnancy.

Authors:  Jessica Ares; Alicia Martín-Nieto; Lucía Díaz-Naya; Teresa Tartón; Teresa Menéndez-Prada; Cecilia S Ragnarsson; Elías Delgado-Álvarez; Edelmiro Menéndez-Torre
Journal:  Matern Child Health J       Date:  2017-07

Review 7.  Nutrition therapy within and beyond gestational diabetes.

Authors:  Teri L Hernandez; Archana Mande; Linda A Barbour
Journal:  Diabetes Res Clin Pract       Date:  2018-04-19       Impact factor: 5.602

8.  Managing diabetes during pregnancy. Guide for family physicians.

Authors:  Ian P Sempowski; R L Houlden
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

Review 9.  Gestational diabetes and nutritional recommendations.

Authors:  Erica P Gunderson
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

10.  Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM.

Authors:  T Filardi; F Tavaglione; M Di Stasio; V Fazio; A Lenzi; S Morano
Journal:  J Endocrinol Invest       Date:  2017-11-17       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.